Download our white paper to discover how we can help you go from DNA-to-IND in 11 months*
This week's Fierce Biotech is brought to you by Lonza. Trouble viewing? Click here.
Download our white paper to discover how we can help you go from DNA-to-IND in 11 months*
How can we help you bring your molecule to the clinic?
From DNA to TOX drug substance in 5 monthsand IND in 11 months* Minimum 1.5 kg GMP drug substance for your phase 1 clinical studies* Flexible commercial terms Improved portability
Our new comprehensive DNA-to-IND program combines speed and quality, while minimizing risk, guaranteeing* delivery of a CMC path to IND for your monoclonal antibodies in just 11 months.
To gain maximum information on your drug candidate as early as possible, your tox drug substance is delivered in only 5 months allowing you to perform toxicological studies before entering GMP manufacturing.
Want to reach 137,000+ Fierce Biotech subscribers with your own message? Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com. If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe. Refer to our Privacy Policy.
Questex, LLC 685 3rd Avenue, 21st Floor New York, NY 10017
